Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

Pfizer said on Monday former head of the US Food and Drug Administration's drug center, Patrizia Cavazzoni, will join the drugmaker as chief medical officer. In her new role, Cavazzoni will lead regulatory,

HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday.  Patrizia Cavazzoni was formerly director of

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. | After leaving the FDA,

Pfizer yesterday revealed that Dr Patrizia Cavazzoni will rejoin the pharma giant as chief medical officer, executive vice president.

Pfizer appoints Patrizia Cavazzoni as chief medical officer, the U.S. delays the definition of 'healthy' on labels, issues with Wegovy and Ozempic's drug shortages lead to lawsuits, new outbreaks of listeria are under investigation,

Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In this role, Dr Cavazzoni will lead

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory and drug safety operations.

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.

Health experts have slammed the FDA as 'corrupt' and 'in bed with Big Pharma' after its former drug chief Dr Patrizia Cavazzoni left the agency to serve as chief medical officer of Pfizer.